Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Seham Skah"'
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/f53139c5d31440628b3d740752414ebf
Autor:
Nina Richartz, Eva Duthil, Anthony Ford, Elin Hallan Naderi, Sampada Bhagwat, Karin M. Gilljam, Marta Maria Burman, Ellen Ruud, Heidi Kiil Blomhoff, Seham Skah
Publikováno v:
Blood Advances, Vol 3, Iss 21, Pp 3181-3190 (2019)
Abstract: Acute lymphoblastic leukemia (ALL) develops in the bone marrow in the vicinity of stromal cells known to promote tumor development and treatment resistance. We previously showed that the cyclooxygenase (COX) inhibitor indomethacin prevents
Externí odkaz:
https://doaj.org/article/0ca2d37f52d940a795fac60d5a81e428
Autor:
Maria Sirakov, Seham Skah, Imtiaz Nisar Lone, Julien Nadjar, Dimitar Angelov, Michelina Plateroti
Publikováno v:
PLoS ONE, Vol 7, Iss 4, p e34162 (2012)
Intestinal homeostasis results from complex cross-regulation of signaling pathways; their alteration induces intestinal tumorigenesis. Previously, we found that the thyroid hormone nuclear receptor TRα1 activates and synergizes with the WNT pathway,
Externí odkaz:
https://doaj.org/article/0c133a07de4848de9278e11ecfed1173
Autor:
Heidi Kiil Blomhoff, Ellen Ruud, Elin Hallan Naderi, Sampada Bhagwat, Bjørn S. Skålhegg, Seham Skah, Karin M. Gilljam, Wojciech Pietka, Nina Richartz
Supplementary Data from cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4765f9084a9adb206aeb1c85738d196a
https://doi.org/10.1158/1541-7786.22528074.v1
https://doi.org/10.1158/1541-7786.22528074.v1
Autor:
Heidi Kiil Blomhoff, Ellen Ruud, Elin Hallan Naderi, Sampada Bhagwat, Bjørn S. Skålhegg, Seham Skah, Karin M. Gilljam, Wojciech Pietka, Nina Richartz
DNA-damaging therapy is the basis for treatment of most cancers, including B-cell precursor acute lymphoblastic leukemia (BCP-ALL, hereafter ALL). We have previously shown that cAMP-activating factors present in the bone marrow render ALL cells less
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9b1f09c2475a512684bd530de8f8cbc5
https://doi.org/10.1158/1541-7786.c.6545607
https://doi.org/10.1158/1541-7786.c.6545607
Autor:
Nina Richartz, Wojciech Pietka, Karin M. Gilljam, Seham Skah, Bjørn S. Skålhegg, Sampada Bhagwat, Elin Hallan Naderi, Ellen Ruud, Heidi Kiil Blomhoff
Publikováno v:
Molecular Cancer Research. 20:400-411
DNA-damaging therapy is the basis for treatment of most cancers, including B-cell precursor acute lymphoblastic leukemia (BCP-ALL, hereafter ALL). We have previously shown that cAMP-activating factors present in the bone marrow render ALL cells less
Publikováno v:
Regular and Young Investigator Award Abstracts.
Publikováno v:
Blood. 140:2609-2609
Autor:
Sampada Bhagwat, Eva Duthil, Heidi Kiil Blomhoff, Marta Maria Burman, Seham Skah, Ellen Ruud, Elin Hallan Naderi, Karin Margaretha Gilljam, Nina Richartz, Anthony M. Ford
Publikováno v:
Blood Advances. 3:3181-3190
Acute lymphoblastic leukemia (ALL) develops in the bone marrow in the vicinity of stromal cells known to promote tumor development and treatment resistance. We previously showed that the cyclooxygenase (COX) inhibitor indomethacin prevents the abilit
Autor:
Elin Hallan Naderi, Heidi Kiil Blomhoff, Ellen Ruud, Nina Richartz, Christian Bindesbøll, Eva Duthil, Marta Maria Dirdal, Anne Simonsen, Agnete Bratsberg Eriksen, Karin Margaretha Gilljam, Seham Skah
Publikováno v:
Oncotarget
Autophagy is important in regulating the balance between cell death and survival, with the tumor suppressor p53 as one of the key components in this interplay. We have previously utilized an in vitro model of the most common form of childhood cancer,